Sabitlenmiş Tweet
Dr. Eduardo Galvan
887 posts

Dr. Eduardo Galvan
@CardioMty
Cardiologo Intervencionista, departamento de Hemodinamia hospital de cardiología UMAE 34, Monterrey NL, Mex. #UMAE34cathlab
Monterrey Nuevo León Katılım Ekim 2013
541 Takip Edilen857 Takipçiler
Dr. Eduardo Galvan retweetledi
Dr. Eduardo Galvan retweetledi

I am very pleased to share our latest publication as first author on management of coronary artery perforations in the Journal of American College of Cardiology(JACC).
Stepwise, case-based review from our UK centre.
🔗 jacc.org/doi/10.1016/j.…
#JACC #cardiology #intervention

English
Dr. Eduardo Galvan retweetledi

Mitral implantation of the Sapien M3 valve at HCU Valladolid.
One team, one direction: The patient.
Thank you to everyone who makes these milestones possible. Worth every sacrifice.
@sacyl @EdwardsLifesci @secardiologia @mariogago13 @AnestesiaHCUV
English

Hanging around on CRF CTO plus 2026 with friends.
@rickytiago @MauroEchavPinto @elpikos @mornei2011 Ulises Lopez, Francisco Díaz y Víctor Romero de BSCI


Times Square, Manhattan 🇺🇸 Español

@mornei2011 @crfheart @ShariqShamimMD @evandrofilhobr @MPAOSS @OjedaOjeda18 @jedicath @LAzzaliniMD @rickytiago @mirvatalasnag @mmamas1973 @Laserrman @RumoJose @realarainmd Great result! See you there.. 😎
English

Last CTO before #CTOplus2026 #CTO2026 RCA CTO post CABG patient #calcium #distalbifurcation previous attempt failed @crfheart @ShariqShamimMD @evandrofilhobr @MPAOSS @OjedaOjeda18 @jedicath @LAzzaliniMD @rickytiago @mirvatalasnag @mmamas1973 @Laserrman @RumoJose @realarainmd
English

@LAzzaliniMD @UWMedHeart @KateKearney4 @DrBillLombardi @RhianEDavies1 @wjn_md @AshishPershad @JAG24851 By extending the way we treat chronic total occlusions, thinking outside the box can facilitate success #umae34cathlab #CHIPLIFE
English
Dr. Eduardo Galvan retweetledi

🗞️ Hot off the press: #STAR trial
First randomized controlled trial comparing two different technical strategies in #CTO #PCI
jacc.org/doi/10.1016/j.…

English
Dr. Eduardo Galvan retweetledi

TAVI or TAVR? A timely #EHJVSHD viewpoint reviews the historical origins, guideline evolution, and semantic accuracy of transcatheter aortic valve therapy, arguing why TAVI best reflects the procedure performed👉🔗ow.ly/o78950XJrMZ
@EHJVSHDEiC @PanichellaG @IndolfiCiro @ESC_President @EAPCIPresident

English
Dr. Eduardo Galvan retweetledi
Dr. Eduardo Galvan retweetledi

Guidelines recommend dual antiplatelet therapy after CABG for acute coronary syndrome, but whether it reduces adverse events as compared with aspirin alone is unclear. Research findings from the TACSI trial are summarized in a new Quick Take video. nej.md/499wznZ

English
Dr. Eduardo Galvan retweetledi

A must-read paper in #EHJ!
Coronary revascularization: a long-term perspective.
A State-of-the-Art review forecasting advancements by 2040, drawing on historical trends and recent breakthroughs.
@escardio @ESC_Journals #CardioTwitter
academic.oup.com/eurheartj/adva…

English

😱 I have been included in the world top 2% scientists in the Stanford University ranking. I understand the limitations of rankings and probably many great scientists are not in that list… but there are days when these small things matter. Thanks 🙏
…s-library-cityu-edu-hk.translate.goog/rim_recognitio…
English
Dr. Eduardo Galvan retweetledi

ACTUALIZACIÓN: CONTRADICCIONES ENTRE PLANTA Y CONCESIONARIO
Adquirí una Volkswagen Tiguan 2025 R-Line el 23 de julio 2025. Confié en la marca y en su seguridad. Hoy, después de 3 ingresos a garantía y casi 3 meses sin mi vehículo, sigo sin solución. @Volkswagen_MX @Profeco

Español
Dr. Eduardo Galvan retweetledi
Dr. Eduardo Galvan retweetledi

Estrategia de reducción de stents frente a revascularización coronaria percutánea convencional en el IAMCEST: diseño del ensayo COPERNICAN #REC #Aheadofprint @sjorge4 @drassantos @EvaRumiz @AntonioGomezM21 @fer_iver @cardioyoguini @hect2701 @ignamatsant revespcardiol.org/es-estrategia-…

Español
Dr. Eduardo Galvan retweetledi

📢 NEW State-of-the-Art Review
Advanced coronary imaging techniques—IVUS, OCT, NIRS, and CCTA—enable detailed assessment of plaque morphology, vulnerability, and therapeutic response.
This comprehensive review by García-García et al. outlines current evidence and clinical implications.
Read here: ow.ly/gxYH50Wtaso
@hect2701 @sjorge4 @christosbouran1
#Cardiology #Atherosclerosis #CoronaryImaging

English

Knowledge, dinner, and friends, great night with @mmamas1973 an friends in #CITIC Mexico City. Hope you had have a safe come back home @mmamas1973




English

@KambisMashayek1 @CtoEuro Oohh god 😭, rest in peace great interventionalist, leaves behind great legacy, condolences to his family.
English

We are deeply saddened by the passing of our esteemed colleague and dear friend, Dr. Dimitri Karmpaliotis. Dimitri was not only a world-class interventionalist, but also a visionary thinker, a generous mentor, and a tireless advocate for better patient care. @CtoEuro
TCTMD@TCTMD
Dimitrios Karmpaliotis, Master Operator and Mentor With ‘Heart of Gold,’ Dies at 53 dlvr.it/TLG79F
English
Dr. Eduardo Galvan retweetledi

New in EuroIntervention🔥
SCAI/EAPCI/ACVC expert consensus on cardiogenic shock in women.
A comprehensive, evidence-based guide to diagnosis, monitoring, and treatment—across CS etiologies and clinical settings. #europcr #eapci #cardiogenicshock
ow.ly/fAn250VVpLr

English
Dr. Eduardo Galvan retweetledi

Are pressure-based indices vessel agnostic? Pressure derived indices in the Left Main @achir76 @drkogallagher @DrOzanDemir @k_desilva @mattlkw @divaka_perera @ukHeartResearch @theBHF #cardiotwitter #AHAJournals ahajrnls.org/3H6YdY0

English











